Skip to main content
Clinical Trials/ISRCTN12859609
ISRCTN12859609Active, not recruitingUnknown

Intensive smoking cessation treatment among patients with a primary mental disorder: a randomized controlled trial

niversity of Siegen0 sites63 target enrollmentStarted: May 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Sponsor
Enrollment
63

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. >18 years of age
  • 2. Exhibition of either harmful use of tobacco (F17.1 according to ICD-10) or tobacco dependence (F17.2 according to ICD-10)
  • 3. Psychiatric primary diagnosis (F-Diagnosis according to ICD-10)

Exclusion Criteria

  • 1. Acute suicidality
  • 2. Acute psychotic epsiode

Investigators

Sponsor
niversity of Siegen

Similar Trials

Active, not recruiting
Phase 1
Sequential treatment with chemotherapy and Blinatumomab to improve the response and survival of patients affected by a form of cancer that affects the cells from which give origin to white cells (cells present in blood)
EUCTR2017-004251-23-ITFONDAZIONE GIMEMA (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) FRANCO MANDELLI ONLUS149
Active, not recruiting
Not Applicable
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphoma
EUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
Not yet recruiting
Not Applicable
Retrospective study on the treatment of patients in specialized outpatient pain therapyChronic Pain
DRKS00031186Charité - Universitätsmedizin Berlin3,000
Active, not recruiting
Phase 1
Clinical trial with chemotherapy for patients with non-resectable locally advanced pancreatic cancer and addition of chemo-radiotherapy for patients with borderline resectable pancreatic cancer. DPSG - ”Danish Pancreatic cancer Study Group”
EUCTR2011-000703-40-DKOdense University Hospital53
Unknown
Not Applicable
Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.Diabetic Nephropathy
JPRN-C000000280Okayama University Hospital600
Intensive smoking cessation treatment... | Clinical Trial